{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:23:27Z","timestamp":1781234607022,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s12350-018-01552-4","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T15:42:54Z","timestamp":1545234174000},"page":"158-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis"],"prefix":"10.1016","volume":"26","author":[{"given":"Vasvi","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo F.","family":"Di Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Kijewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Rapezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila","family":"Dorbala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-018-01552-4_bib1","doi-asserted-by":"crossref","unstructured":"Adams D, Gonzalez-Duarte A, O\u2019Riordan WD, Yang CC, Ueda M, Adams AV, et al. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis. N Engl J Med 2018;379:11-21.","DOI":"10.1056\/NEJMoa1716153"},{"key":"10.1007\/s12350-018-01552-4_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-018-01552-4_bib3","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk","year":"2005","journal-title":"Circulation"},{"key":"10.1007\/s12350-018-01552-4_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1404852","article-title":"The amyloidogenic V122I transthyretin variant in elderly black Americans","volume":"372","author":"Quarta","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-018-01552-4_bib5","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin Hematol"},{"key":"10.1007\/s12350-018-01552-4_bib6","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"10.1007\/s12350-018-01552-4_bib7","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s12325-015-0250-0","article-title":"Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium","volume":"32","author":"Lousada","year":"2015","journal-title":"Adv Ther"},{"key":"10.1007\/s12350-018-01552-4_bib8","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","article-title":"Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis","volume":"129","author":"Quarta","year":"2014","journal-title":"Circulation"},{"key":"10.1007\/s12350-018-01552-4_bib9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic Resonance in Transthyretin Cardiac Amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-01552-4_bib10","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/eurheartj\/ehx047","article-title":"Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis","volume":"38","author":"Quarta","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-018-01552-4_bib11","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1007\/s12350-018-01552-4_bib12","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-01552-4_bib13","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-018-01552-4_bib14","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archinte.1987.00370060035007","article-title":"Utility of technetium Tc 99 m pyrophosphate bone scanning in cardiac amyloidosis","volume":"147","author":"Gertz","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1007\/s12350-018-01552-4_bib15","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1172\/JCI108421","article-title":"Pathophysiology of technetium-99 m stannous pyrophosphate and thallium-201 scintigraphy of acute anterior myocardial infarcts in dogs","volume":"57","author":"Buja","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1007\/s12350-018-01552-4_bib16","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1172\/JCI108825","article-title":"Sites and mechanisms of localization of technetium-99 m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues","volume":"60","author":"Buja","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1007\/s12350-018-01552-4_bib17","first-page":"639","article-title":"Mechanism of localization of 99 mTc-labeled pyrophosphate and tetracycline in infarcted myocardium","volume":"17","author":"Dewanjee","year":"1976","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-01552-4_bib18","first-page":"284","article-title":"Binding of serum amyloid P-component (SAP) by amyloid fibrils","volume":"38","author":"Pepys","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"10.1007\/s12350-018-01552-4_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.carpath.2016.07.001","article-title":"Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis","volume":"25","author":"Stats","year":"2016","journal-title":"Cardiovasc Pathol"},{"key":"10.1007\/s12350-018-01552-4_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99 m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-018-01552-4_bib21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","article-title":"Role of (99 m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis","volume":"4","author":"Rapezzi","year":"2011","journal-title":"JACC Cardiovascular imaging"},{"key":"10.1007\/s12350-018-01552-4_bib22","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99 mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-01552-4_bib23","unstructured":"Abulizi M, Cottereau AS, Guellich A, Vandeventer S, Galat A, Van Der Gucht A et al. Early-phase myocardial uptake intensity of 99 mTc-HMDP vs 99 mTc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis. J Nucl Cardiol 2016."},{"key":"10.1007\/s12350-018-01552-4_bib24","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","article-title":"Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis","volume":"15","author":"Hutt","year":"2014","journal-title":"European heart journal cardiovascular Imaging"},{"key":"10.1007\/s12350-018-01552-4_bib25","doi-asserted-by":"crossref","unstructured":"Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R et al. Multicenter Study of Planar Technetium 99 m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. JAMA Cardiol 2016.","DOI":"10.1001\/jamacardio.2016.2839"},{"key":"10.1007\/s12350-018-01552-4_bib26","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s12350-015-0261-x","article-title":"Serial scanning with technetium pyrophosphate ((99m)Tc-PYP) in advanced ATTR cardiac amyloidosis","volume":"23","author":"Castano","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-01552-4_bib27","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00259-010-1642-7","article-title":"Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy","volume":"38","author":"Rapezzi","year":"2011","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"10.1007\/s12350-018-01552-4_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/13506129.2015.1072089","article-title":"Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis","volume":"22","author":"Galat","year":"2015","journal-title":"Amyloid"},{"key":"10.1007\/s12350-018-01552-4_bib29","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.amjmed.2015.05.039","article-title":"Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology","volume":"128","author":"Maurer","year":"2015","journal-title":"Am J Med"},{"key":"10.1007\/s12350-018-01552-4_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0140-6736(77)91102-3","article-title":"Scanning for soft-tissue amyloid","volume":"1","author":"Kula","year":"1977","journal-title":"Lancet"},{"key":"10.1007\/s12350-018-01552-4_bib31","doi-asserted-by":"crossref","unstructured":"Sperry BW, Gonzalez MH, Brunken R, Cerqueira MD, Hanna M, Jaber WA. Non-cardiac uptake of technetium-99m pyrophosphate in transthyretin cardiac amyloidosis. J Nucl Cardiol 2018.","DOI":"10.1007\/s12350-017-1166-7"},{"key":"10.1007\/s12350-018-01552-4_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/03009734.2015.1122687","article-title":"(99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis","volume":"121","author":"Pilebro","year":"2016","journal-title":"Ups J Med Sci"},{"key":"10.1007\/s12350-018-01552-4_bib33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12350-016-0638-5","article-title":"Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR)","volume":"25","author":"Pilebro","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-01552-4_bib34","first-page":"618","article-title":"Frequency and distribution of senile cardiovascular amyloid","volume":"75","author":"Cornwell","year":"1983","journal-title":"A clinicopathologic correlation. Am J Med"},{"key":"10.1007\/s12350-018-01552-4_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/hrt.27.5.711","article-title":"Senile cardiac amyloidosis","volume":"27","author":"Pomerance","year":"1965","journal-title":"Br Heart J"},{"key":"10.1007\/s12350-018-01552-4_bib36","doi-asserted-by":"crossref","unstructured":"Haq M, Pawar S, Berk JL, Miller EJ, Ruberg FL. Can 99m-Tc-Pyrophosphate Aid in Early Detection of Cardiac Involvement in Asymptomatic Variant TTR Amyloidosis? JACC Cardiovasc imaging 2016.","DOI":"10.1016\/j.jcmg.2016.06.003"},{"key":"10.1007\/s12350-018-01552-4_bib37","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10554-016-0915-z","article-title":"Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy","volume":"32","author":"Bennani Smires","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1007\/s12350-018-01552-4_bib38","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonzalez-Lopez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-018-01552-4_bib39","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Castano","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-018-01552-4_bib40","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release","volume":"72","author":"Sperry","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-01552-4_bib41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jcmg.2014.03.004","article-title":"Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy","volume":"7","author":"Longhi","year":"2014","journal-title":"JACC Cardiovascular imaging"},{"key":"10.1007\/s12350-018-01552-4_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2018.06.006","article-title":"Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population","volume":"270","author":"Mohamed-Salem","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-018-01552-4_bib43","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCIMAGING.113.001396","article-title":"How to image cardiac amyloidosis","volume":"7","author":"Falk","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-018-01552-4_bib44","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","article-title":"Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid","volume":"18","author":"Hutt","year":"2017","journal-title":"European heart journal cardiovascular Imaging"},{"key":"10.1007\/s12350-018-01552-4_bib45","unstructured":"Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy; 2014."},{"key":"10.1007\/s12350-018-01552-4_bib46","unstructured":"Phase 2 Study to Evaluate ALN-TTRSC (Revusiran) in Patients With Transthyretin (TTR) Cardiac Amyloidosis; 2014."},{"key":"10.1007\/s12350-018-01552-4_bib47","unstructured":"Tolerability and Efficacy of a Combination of Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy; 2013."},{"key":"10.1007\/s12350-018-01552-4_bib48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.22068","article-title":"18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial","volume":"68","author":"Vandenberghe","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1007\/s12350-018-01552-4_bib49","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using (18)F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"10.1007\/s12350-018-01552-4_bib50","doi-asserted-by":"crossref","unstructured":"Law WP, Wang WY, Moore PT, Mollee PN, Ng AC. Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study. J Nucl Med 2016.","DOI":"10.2967\/jnumed.115.169870"},{"key":"10.1007\/s12350-018-01552-4_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fcvm.2015.00023","article-title":"A routine PET\/CT protocol with simple calculations for assessing cardiac amyloid using 18F-Florbetapir","volume":"2","author":"Osborne","year":"2015","journal-title":"Front Cardiovasc Med"},{"key":"10.1007\/s12350-018-01552-4_bib52","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","article-title":"In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET","volume":"54","author":"Antoni","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-01552-4_bib53","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.002954","article-title":"18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study","volume":"8","author":"Park","year":"2015","journal-title":"Circ Cardiovasc imaging"},{"key":"10.1007\/s12350-018-01552-4_bib54","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/13506129.2017.1281120","article-title":"Cardiac amyloid imaging with (18)F-florbetaben positron emission tomography: a pilot study","volume":"24","author":"Law","year":"2017","journal-title":"Amyloid"},{"key":"10.1007\/s12350-018-01552-4_bib55","unstructured":"Dorbala S, Bokhari S, Miller E, Bullock-Palmer R, Soman P, Thompson R. ASNC Practice Points: 99mTechnetium-Pyrophosphate Imaging for Transthyretin Cardiac Amyloidosis 2016."},{"key":"10.1007\/s12350-018-01552-4_bib56","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcmg.2015.04.012","article-title":"Coexistence of degenerative aortic stenosis and wild-type transthyretin-related cardiac amyloidosis","volume":"9","author":"Longhi","year":"2016","journal-title":"JACC Cardiovascular imaging"},{"key":"10.1007\/s12350-018-01552-4_bib57","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1039\/C4CS00026A","article-title":"Metal complexes designed to bind to amyloid-beta for the diagnosis and treatment of Alzheimer\u2019s disease","volume":"43","author":"Hayne","year":"2014","journal-title":"Chem Soc Rev"},{"key":"10.1007\/s12350-018-01552-4_bib58","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fnins.2018.00585","article-title":"Imaging protein misfolding in the brain using beta-sheet ligands","volume":"12","author":"Harada","year":"2018","journal-title":"Front Neurosci"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-018-01552-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-01552-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123060981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123060981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-01552-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:03:53Z","timestamp":1761026633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123060981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1071358123060981"],"URL":"https:\/\/doi.org\/10.1007\/s12350-018-01552-4","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-018-01552-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}